Consolidated Statements of Shareholders' Equity (Deficit) (Unaudited) - USD ($)	Common Stock	Additional Paid-In Capital	Retained Earnings (accumulated deficits)	Total
Beginning balance, shares at Dec. 31, 2017	25,046,000
Beginning balance, value at Dec. 31, 2017	$ 25,036	$ 3,258,116	$ (4,644,180)	$ (1,361,028)
Clawback of stock granted, shares	(375,000)			0
Clawback of stock granted, value	$ (375)	375
Payment of outstanding balance of PPM		80,000		$ 80,000
Stock Grant Program		199,850		199,850
Net loss for period			(782,649)	(782,649)
Ending balance, shares at Mar. 31, 2018	24,671,000
Ending balance, value at Mar. 31, 2018	$ 24,661	3,538,341	(5,426,829)	(1,863,827)
Beginning balance, shares at Dec. 31, 2018	25,229,833
Beginning balance, value at Dec. 31, 2018	$ 25,230	4,688,272	(8,540,053)	(3,826,551)
Stock Based Compensation		588,697		588,697
Stock Options Issued for Loan Term Revisions		17,827		17,827
Stock Grant Program Vesting, shares	20,000
Stock Grant Program Vesting, value	$ 20	(20)		0
Stock Issuance Related to Acquisition, shares	500,000
Stock Issuance Related to Acquisition, value	$ 500	999,500		1,000,000
Warrant Issuance Related to Convertible Debentures		101,741		101,741
Equity value of exercise price associated with convertible debentures		119,212		119,212
Net loss for period			(1,481,471)	(1,481,471)
Ending balance, shares at Mar. 31, 2019	25,749,833
Ending balance, value at Mar. 31, 2019	$ 25,750	$ 6,515,229	$ (10,021,524)	$ (3,480,545)